Interventional cardiology in a whole new light

Open menu

News & Events

Opsens – Q3 Results

29 June 2017

OPSENS REPORTS Q3 2017 RESULTS  ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights Growth in sales of products to measure Fractional Flow Reserve (“FFR”) in Q3 2017 to…

Read more

VISIT OPSENS MEDICAL AT THE 13TH ANNUAL C3 CONFERENCE

9 June 2017

Learn more about OptoWire Deux at booth #211 at the 13th Annual Complex Cardiovascular Catheter Therapeutics (C3) Conference, and attend the Opsens sponsored complimentary breakfast educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared toward the interventionalist seeking to better understand complex PCI in the modern era. Presentations will…

Read more

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER

7 June 2017

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER Quebec City, Quebec, June 7, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve as Chief Financial Officer. This appointment enters into force immediately. Mr. Villeneuve recently worked as…

Read more